The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald ...
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...
More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...
In early 2025, the FDA was rocked by sweeping layoffs and leadership turnover, raising questions about whether the agency ...
An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...
Americans cannot rely on the Food & Drug Administration (FDA) to guarantee that medical devices are safe, and a recent Government Accountability ...
For pet owners who dread how short a dog's life can be, a beef-flavored tablet could offer real hope for more time together.
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback